Citi Maintains Cencora(COR.US) With Buy Rating, Maintains Target Price $284
Cencora Cut to Neutral From Buy by B of A Securities
Cencora Analyst Ratings
BofA Securities Downgrades Cencora(COR.US) to Hold Rating, Cuts Target Price to $245
Wells Fargo Maintains Cencora(COR.US) With Hold Rating, Maintains Target Price $249
Cencora: A Balanced Future Outlook Justifies Hold Rating Amid Modest Growth Projections
Baird Maintains Cencora(COR.US) With Buy Rating, Cuts Target Price to $283
A Quick Look at Today's Ratings for Cencora(COR.US), With a Forecast Between $249 to $283
Cencora Is Maintained at Outperform by Baird
Cencora Analyst Ratings
Cencora's Resilience Amid Challenges Spurs Buy Rating and Positive Growth Outlook
Cencora (COR) Gets a Buy From Barclays
Evercore ISI Adjusts Price Target on Cencora to $270 From $260
Cencora Analyst Ratings
JPMorgan Adjusts Price Target on Cencora to $287 From $280, Maintains Overweight Rating
Evercore ISI Adjusts Price Target on Cencora to $260 From $270, Maintains Outperform Rating
Argus Research Keeps Their Buy Rating on Cencora (COR)
A Quick Look at Today's Ratings for Cencora(COR.US), With a Forecast Between $242 to $287
Analysts Conflicted on These Healthcare Names: Cencora (COR), Schrodinger (SDGR) and Biogen (BIIB)
A Quick Look at Today's Ratings for Cencora(COR.US), With a Forecast Between $249 to $287
No Data
No Data